CV Ventures
2
375K
2
1
- Areas of investment
Summary
The leading representative office of defined VC is situated in the Hong Kong. The company was established in Asia in Hong Kong.
The fund is constantly included in less than 2 investment rounds annually. The common things for fund are deals in the range of 100 thousands - 1 million dollars. The top amount of exits for fund were in 2016. The important activity for fund was in 2013.
We also calculated 1 valuable employee in our database.
The typical case for the fund is to invest in rounds with 1 participant. In the next rounds fund is usually obtained by Vectr, Treuenburg Group, Mountain Partners.
We can highlight the next thriving fund investment areas, such as Financial Services, Medical Device. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the various public portfolio startups of the fund, we may underline Restore Flow Allografts
Investments analytics
Analytics
- Total investments
- 2
- Lead investments
- 0
- Exits
- 1
- Investments by industry
- Financial Services (1)
- Personal Finance (1)
- FinTech (1)
- Life Science (1)
- Medical Device (1) Show 2 more
- Investments by region
-
- United States (1)
- China (1)
- Peak activity year
- 2016
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 6
- Avg. valuation at time of investment
- 7M
- Avg. company exit year
- 3
- Avg. multiplicator
- 18.67
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Restore Flow Allografts | 12 Jun 2013 | Biotechnology, Health Care, Medical Device, Life Science | Seed | 750K | United States, Illinois, Chicago |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.